SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-17-029466
Filing Date
2017-12-22
Accepted
2017-12-22 16:12:03
Documents
2
Period of Report
2017-12-11

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 3813
2 EX-24 DOCUMENT attachment1.htm EX-24 3670
  Complete submission text file 0000899243-17-029466.txt   9220
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Issuer) CIK: 0000897448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMARIN PHARMA, INC. 1430 ROUTE 206, SUITE 200 BEDMINSTER NJ 07921
Business Address
Salyer Mark (Reporting) CIK: 0001725833 (see all company filings)

Type: 3/A | Act: 34 | File No.: 000-21392 | Film No.: 171272834